Skip Navigation LinksHome > December 2012 - Volume 11 - Issue 4 > Laboratory Profile of Current Injecting Drug Users Seeking T...
Addictive Disorders & Their Treatment:
doi: 10.1097/ADT.0b013e3182404043
Original Articles

Laboratory Profile of Current Injecting Drug Users Seeking Treatment at a Tertiary Care Center in India: What do the Regular Blood Tests and HIV Screening Say?

Quraishi, Rizwana PhD; Jain, Raka PhD, CChem, FRSC; Pattanayak, Raman Deep MD

Collapse Box

Abstract

Objectives: The aim of the study was to describe the profile of injection drug users (IDUs) visiting a tertiary care center in north India.

Methods: A retrospective study was conducted for 63 IDUs who sought treatment over a period of 6 months, were regular current users of the injecting drugs, and underwent blood/urine testing at the laboratory.

Results: The mean age of sample was 29.92±6.27 years, and all were male patients. The mean age at onset of injection use was 25.81±6.61 years. Nearly 60.3% patients regularly chased heroin for an average of 7.5 years before injection use. The most commonly injected drug was pentazocine (35.4%), followed by buprenorphine (28.6%) and heroin (27%), and the use of opioids was confirmed on urinalysis in 75% of patients. The hemoglobin ranged between 7.50 and 13.50 g/dL. At least 1 abnormality in the differential leukocyte count was found in 39.7% (n=25) of sample. Further, 57% of patients with any specific or nonspecific medical complaint and 30.9% of patients with no overt medical complaint had leukocyte abnormality. Erythrocyte sedimentation rate was increased in two thirds of tested patients. Hypoalbuminemia was present in 41.3%, serum glutamic oxaloacetic transaminase was elevated in 25.4%, serum glutamic pyruvic transaminase in 20.6%, γ-glutamyl transpeptidase in 31.8%, and alkaline phosphatase in 54% of IDUs. The human immunodeficiency virus enzyme-linked immunosorbent assay was found to be positive in 7.9% of patients.

Conclusions: The findings add to the limited number of studies on profile of treatment-seeking IDUs from northern India. The study pointed to the presence of hematological abnormalities in IDUs complaining of nonspecific symptoms or, even, no overt medical symptoms.

Copyright © 2012 Wolters Kluwer Health, Inc. All rights reserved

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.